Skip to main content

Asenapine News

FDA Approves Secuado (asenapine) Transdermal System for the Treatment of Adults with Schizophrenia

Miami, FL And Jersey City, NJ, October 15, 2019 -- Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced the U.S. Food and Drug Administration ...

Actavis Receives FDA Approval of Saphris for Pediatric Patients with Bipolar I Disorder

DUBLIN, March 13, 2015 /PRNewswire/ – Actavis plc (NYSE: ACT) today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental new drug application (sNDA) for Saphris...

FDA Medwatch Alert: Saphris (asenapine maleate): Drug Safety Communication: Serious Allergic Reactions

[Posted 09/01/2011] ISSUE: FDA notified healthcare professionals and patients that serious allergic reactions have been reported with the use of Saphris (asenapine maleate). The Contraindications,...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Schizoaffective Disorder, Bipolar Disorder, Schizophrenia, Borderline Personality Disorder, Post Traumatic Stress Disorder

Asenapine patient information at Drugs.com